nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0875	0.262	CbGeAlD
Mivacurium—CHRNA1—tongue—amyotrophic lateral sclerosis	0.0648	0.194	CbGeAlD
Mivacurium—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0528	0.156	CcSEcCtD
Mivacurium—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0333	0.0985	CcSEcCtD
Mivacurium—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0283	0.0835	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0252	0.0743	CcSEcCtD
Mivacurium—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0507	CcSEcCtD
Mivacurium—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0462	CcSEcCtD
Mivacurium—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.0153	0.0459	CbGeAlD
Mivacurium—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0451	CcSEcCtD
Mivacurium—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0449	CcSEcCtD
Mivacurium—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0448	CcSEcCtD
Mivacurium—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.015	0.0444	CcSEcCtD
Mivacurium—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0416	CcSEcCtD
Mivacurium—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.0137	0.0409	CbGeAlD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0366	CcSEcCtD
Mivacurium—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.0124	0.0371	CbGeAlD
Mivacurium—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.012	0.0366	CbGpPWpGaD
Mivacurium—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.012	0.0353	CcSEcCtD
Mivacurium—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.0119	0.0357	CbGeAlD
Mivacurium—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0345	CcSEcCtD
Mivacurium—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.0117	0.0349	CbGeAlD
Mivacurium—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0343	CcSEcCtD
Mivacurium—CHRNA1—brain—amyotrophic lateral sclerosis	0.0114	0.0341	CbGeAlD
Mivacurium—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0112	0.033	CcSEcCtD
Mivacurium—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.0108	0.0325	CbGeAlD
Mivacurium—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00951	0.0281	CcSEcCtD
Mivacurium—CHRNA2—brain—amyotrophic lateral sclerosis	0.00947	0.0283	CbGeAlD
Mivacurium—BCHE—brainstem—amyotrophic lateral sclerosis	0.00937	0.0281	CbGeAlD
Mivacurium—CHRNB1—brain—amyotrophic lateral sclerosis	0.00881	0.0264	CbGeAlD
Mivacurium—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00791	0.0234	CcSEcCtD
Mivacurium—Rash—Riluzole—amyotrophic lateral sclerosis	0.00755	0.0223	CcSEcCtD
Mivacurium—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0223	CcSEcCtD
Mivacurium—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00739	0.0221	CbGeAlD
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00718	0.0219	CbGpPWpGaD
Mivacurium—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00711	0.0213	CbGeAlD
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00662	0.0202	CbGpPWpGaD
Mivacurium—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00654	0.0196	CbGeAlD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0061	0.0186	CbGpPWpGaD
Mivacurium—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00602	0.018	CbGeAlD
Mivacurium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00585	0.0179	CbGpPWpGaD
Mivacurium—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00583	0.0174	CbGeAlD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0058	0.0177	CbGpPWpGaD
Mivacurium—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00579	0.0173	CbGeAlD
Mivacurium—CHRM2—brain—amyotrophic lateral sclerosis	0.00565	0.0169	CbGeAlD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00563	0.0172	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00539	0.0165	CbGpPWpGaD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00535	0.0163	CbGpPWpGaD
Mivacurium—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00502	0.0153	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00498	0.0152	CbGpPWpGaD
Mivacurium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00497	0.0152	CbGpPWpGaD
Mivacurium—BCHE—nervous system—amyotrophic lateral sclerosis	0.00491	0.0147	CbGeAlD
Mivacurium—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00481	0.0147	CbGpPWpGaD
Mivacurium—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00473	0.0142	CbGeAlD
Mivacurium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00472	0.0144	CbGpPWpGaD
Mivacurium—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00472	0.0144	CbGpPWpGaD
Mivacurium—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00464	0.0142	CbGpPWpGaD
Mivacurium—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00462	0.0138	CbGeAlD
Mivacurium—CHRM3—brain—amyotrophic lateral sclerosis	0.0046	0.0138	CbGeAlD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00459	0.014	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0044	0.0134	CbGpPWpGaD
Mivacurium—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.0044	0.0134	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00436	0.0133	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00423	0.0129	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00413	0.0126	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00409	0.0125	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00409	0.0125	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00409	0.0125	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00402	0.0123	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00388	0.0119	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00381	0.0117	CbGpPWpGaD
Mivacurium—BCHE—brain—amyotrophic lateral sclerosis	0.00375	0.0112	CbGeAlD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00374	0.0114	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00368	0.0113	CbGpPWpGaD
Mivacurium—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00364	0.0111	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00355	0.0109	CbGpPWpGaD
Mivacurium—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00351	0.0107	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00351	0.0107	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00348	0.0106	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00348	0.0106	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00337	0.0103	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00334	0.0102	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0033	0.0101	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0033	0.0101	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00324	0.00991	CbGpPWpGaD
Mivacurium—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00324	0.00989	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00313	0.00957	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00313	0.00957	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00313	0.00957	CbGpPWpGaD
Mivacurium—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0031	0.00947	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00308	0.00941	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00298	0.00909	CbGpPWpGaD
Mivacurium—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00294	0.00899	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00286	0.00875	CbGpPWpGaD
Mivacurium—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00279	0.00853	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00272	0.00832	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00266	0.00814	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00266	0.00814	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00263	0.00803	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00253	0.00773	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00253	0.00773	CbGpPWpGaD
Mivacurium—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00245	0.00749	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0024	0.00735	CbGpPWpGaD
Mivacurium—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00237	0.00725	CbGpPWpGaD
Mivacurium—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00226	0.00689	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00222	0.00678	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00217	0.00662	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00214	0.00655	CbGpPWpGaD
Mivacurium—CHRM3—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00202	0.00617	CbGpPWpGaD
Mivacurium—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.002	0.00611	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00196	0.00599	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0019	0.00581	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00184	0.00563	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00182	0.00557	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00182	0.00557	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00174	0.00531	CbGpPWpGaD
Mivacurium—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00174	0.0053	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0017	0.00519	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00169	0.00517	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00169	0.00517	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00169	0.00517	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00164	0.00502	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00164	0.00502	CbGpPWpGaD
Mivacurium—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.00496	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00162	0.00494	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00152	0.00464	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.0015	0.00459	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0015	0.00459	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0014	0.00427	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0014	0.00427	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00124	0.0038	CbGpPWpGaD
Mivacurium—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.0038	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00122	0.00373	CbGpPWpGaD
Mivacurium—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00121	0.00371	CbGpPWpGaD
Mivacurium—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00121	0.0037	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00104	0.00318	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00103	0.00313	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000979	0.00299	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00097	0.00296	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000876	0.00268	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000863	0.00264	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000847	0.00259	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000847	0.00259	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000789	0.00241	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000774	0.00237	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000746	0.00228	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000738	0.00226	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000734	0.00224	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00072	0.0022	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000677	0.00207	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000651	0.00199	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000651	0.00199	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000612	0.00187	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000595	0.00182	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000554	0.00169	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000542	0.00166	CbGpPWpGaD
Mivacurium—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000532	0.00163	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00052	0.00159	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000471	0.00144	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000464	0.00142	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000437	0.00134	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000428	0.00131	CbGpPWpGaD
Mivacurium—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000427	0.00131	CbGpPWpGaD
Mivacurium—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000423	0.00129	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000421	0.00129	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000417	0.00128	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00039	0.00119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000383	0.00117	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000379	0.00116	CbGpPWpGaD
Mivacurium—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000371	0.00113	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000357	0.00109	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000352	0.00107	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000329	0.00101	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000325	0.000994	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000322	0.000985	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000321	0.00098	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000298	0.000911	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000295	0.000903	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00028	0.000857	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000278	0.000849	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00027	0.000826	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000266	0.000812	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000263	0.000804	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000257	0.000787	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000255	0.000779	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000229	0.0007	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000229	0.000699	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000226	0.000692	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000226	0.000691	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000224	0.000684	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00022	0.000672	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000189	0.000577	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000189	0.000577	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000187	0.000572	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000184	0.000562	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000182	0.000557	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000174	0.000531	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000167	0.00051	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000165	0.000505	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000155	0.000475	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000154	0.00047	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000146	0.000445	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000145	0.000444	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000144	0.000441	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000143	0.000437	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000139	0.000424	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000137	0.00042	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000134	0.000408	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000119	0.000363	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000118	0.000359	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000112	0.000341	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000111	0.000338	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	0.00011	0.000336	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.87e-05	0.000301	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.79e-05	0.000299	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.77e-05	0.000299	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.19e-05	0.000281	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.1e-05	0.000278	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.59e-05	0.000232	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.53e-05	0.00023	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.52e-05	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.84e-05	0.000179	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.79e-05	0.000177	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.52e-05	0.000169	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.47e-05	0.000167	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.96e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.91e-05	0.00015	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.75e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.71e-05	0.000113	CbGpPWpGaD
